{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:02:10Z","timestamp":1775869330665,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.forsciint.2025.112677","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:36:57Z","timestamp":1759538217000},"page":"112677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Metabolite ratios and detection times in urine following a single dose of zopiclone"],"prefix":"10.1016","volume":"378","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8873-8993","authenticated-orcid":false,"given":"Munchelou M.","family":"Gomonit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnel H.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Nystr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liselotte","family":"Berglund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik C.","family":"Kugelberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Ahlner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael T.","family":"Truver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Kronstrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2025.112677_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jsmc.2022.03.003","article-title":"Epidemiology of insomnia","volume":"17","author":"Morin","year":"2022","journal-title":"Sleep. Med. Clin."},{"key":"10.1016\/j.forsciint.2025.112677_bib2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.smrv.2015.11.004","article-title":"Health economics of insomnia treatments: the return on investment for a good night\u2019s sleep","volume":"30","author":"Wickwire","year":"2016","journal-title":"Sleep. Med. Rev."},{"key":"10.1016\/j.forsciint.2025.112677_bib3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1207\/S15402010BSM0104_5","article-title":"Insomnia as a health risk factor","volume":"1","author":"Taylor","year":"2003","journal-title":"Behav. Sleep. Med."},{"key":"10.1016\/j.forsciint.2025.112677_bib4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pbb.2008.01.001","article-title":"Abuse and dependence liability of benzodiazepine-type drugs: GABAA receptor modulation and beyond","volume":"90","author":"Licata","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.forsciint.2025.112677_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13181-013-0292-0","article-title":"The clinical and forensic toxicology of Z-drugs","volume":"9","author":"Gunja","year":"2013","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112677_bib6","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s40264-024-01424-6","article-title":"Fatal intoxications with Zopiclone\u2014A cause for concern?","volume":"47","author":"Tralla","year":"2024","journal-title":"Drug Saf."},{"key":"10.1016\/j.forsciint.2025.112677_bib7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2165\/00003088-199529060-00004","article-title":"Clinical pharmacokinetics of zopiclone","volume":"29","author":"Fernandez","year":"1995","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.forsciint.2025.112677_bib8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/ijnp\/pyz007","article-title":"An insight into Z-Drug abuse and dependence: an examination of reports to the european medicines agency database of suspected adverse drug reactions","volume":"22","author":"Schifano","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.forsciint.2025.112677_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2165\/00003495-198632010-00003","article-title":"Zopiclone","volume":"32","author":"Goa","year":"1986","journal-title":"Drugs"},{"key":"10.1016\/j.forsciint.2025.112677_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/jat\/bku042","article-title":"Quantitative analysis of zopiclone, N-desmethylzopiclone, zopiclone N-oxide and 2-Amino-5-chloropyridine in urine using LC\u2013MS-MS","volume":"38","author":"Nilsson","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112677_bib11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000137914","article-title":"Pharmacokinetics and metabolism of zopiclone","volume":"27","author":"Gaillot","year":"1983","journal-title":"Pharmacology"},{"key":"10.1016\/j.forsciint.2025.112677_bib12","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0090-9556(24)15027-1","article-title":"Cytochrome P-450 3A4 and 2C8 are involved in zopiclone metabolism","volume":"27","author":"Becquemont","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.forsciint.2025.112677_bib13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/jat\/bky083","article-title":"Detection time of oxazepam and zopiclone in urine and oral fluid after experimental oral dosing","volume":"43","author":"Bruun","year":"2019","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112677_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.chroma.2012.06.023","article-title":"The evaluation of the applicability of a high ph mobile phase in ultrahigh performance liquid chromatography tandem mass spectrometry analysis of benzodiazepines and benzodiazepine-like hypnotics in urine and blood","volume":"1249","author":"Verplaetse","year":"2012","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.forsciint.2025.112677_bib15","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/jat\/29.7.616","article-title":"Validation of a liquid Chromatography-Tandem mass spectrometry method for the simultaneous determination of 26 benzodiazepines and metabolites, zolpidem and zopiclone, in blood, urine, and hair","volume":"29","author":"Laloup","year":"2005","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112677_bib16","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1373\/clinchem.2005.065631","article-title":"Liquid Chromatography\u2013Tandem mass spectrometry for detection of low concentrations of 21 benzodiazepines, metabolites, and analogs in urine: method with forensic applications","volume":"52","author":"Quintela","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.forsciint.2025.112677_bib17","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jpba.2011.06.007","article-title":"A fast liquid chromatography\u2013tandem mass spectrometry method for determining benzodiazepines and analogues in urine. Validation and application to real cases of forensic interest","volume":"56","author":"Salomone","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.forsciint.2025.112677_bib18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/dta.1470","article-title":"UHPLC-MS\/MS and UHPLC-HRMS identification of zolpidem and zopiclone main urinary metabolites and method development for their toxicological determination","volume":"6","author":"Strano Rossi","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2025.112677_bib19","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00007691-200206000-00014","article-title":"Chromatographic screening for zopiclone and metabolites in urine using liquid chromatography and liquid Chromatography\u2013Mass spectrometry techniques","volume":"24","author":"Nordgren","year":"2002","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.forsciint.2025.112677_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/FTD.0b013e3181676186","article-title":"The role of liquid Chromatography-Tandem mass spectrometry (LC-MS\/MS) to test blood and urine samples for the toxicological investigation of Drug-Facilitated crimes","volume":"30","author":"Deveaux","year":"2008","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.forsciint.2025.112677_bib21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/jat\/21.3.208","article-title":"Detection of 2-Amino-5-Chloropyridine in urine as a parameter of zopiclone (Imovane\u00ae) intake using HPLC with diode array detection","volume":"21","author":"Mannaert","year":"1997","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112677_bib22","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/jat\/32.8.586","article-title":"Urinary detection times and Metabolite\/Parent compound ratios after a single dose of buprenorphine","volume":"32","author":"Kronstrand","year":"2008","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112677_bib23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/jat\/33.8.491","article-title":"Urinary detection times and excretion patterns of flunitrazepam and its metabolites after a single oral dose","volume":"33","author":"Forsman","year":"2009","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112677_bib24","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/jat\/bkab123","article-title":"Urinary pharmacokinetics of immediate and controlled release oxycodone and its phase I and II metabolites using LC\u2013MS-MS","volume":"46","author":"Truver","year":"2022","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112677_bib25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/ndtplus\/sfq211","article-title":"Creatinine determination according to Jaffe--what does it stand for?","volume":"4","author":"Delanghe","year":"2011","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.forsciint.2025.112677_bib26","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1016\/j.jchromb.2010.04.025","article-title":"GC\u2013MS determination of creatinine in human biological fluids as pentafluorobenzyl derivative in clinical studies and biomonitoring: Inter-laboratory comparison in urine with Jaff\u00e9, HPLC and enzymatic assays","volume":"878","author":"Tsikas","year":"2010","journal-title":"J. Chromatogr. B"}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073825003214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073825003214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T22:32:00Z","timestamp":1764973920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073825003214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":26,"alternative-id":["S0379073825003214"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2025.112677","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolite ratios and detection times in urine following a single dose of zopiclone","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2025.112677","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112677"}}